Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_assertion type Assertion NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_head.
- NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_assertion description "[The PLA(2) enzymes, and sPLA(2)-IIA in particular, thus represent important targets for the treatment of sPLA(2)-IIA-positive androgen-independent prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_provenance.
- NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_assertion evidence source_evidence_literature NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_provenance.
- NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_assertion SIO_000772 15466184 NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_provenance.
- NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_assertion wasDerivedFrom befree-20150227 NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_provenance.
- NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_assertion wasGeneratedBy ECO_0000203 NP795583.RAJwjsfIX6bJUrwWVzlZWSX6Miowjpwt5uc5CUGDJRr6o130_provenance.